Rua Bioscience Limited (NZE: RUA)
New Zealand
· Delayed Price · Currency is NZD 0.0300
+0.0010 (3.45%)
Jan 3, 2025, 3:02 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 4.91 million as of January 3, 2025. Its market cap has decreased by -73.90% in one year.
Market Cap
4.91M
Enterprise Value
4.16M
Revenue
316.35K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 4.91M, a decrease of -94.84%. That is a compound annual growth rate of -50.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 4.91M | 3.45% |
| Dec 31, 2024 | 4.75M | -74.98% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | 84.16M | -11.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 22.27B |
| EBOS Group | 7.27B |
| Ryman Healthcare | 3.21B |
| Summerset Group Holdings | 3.12B |
| Oceania Healthcare | 535.87M |
| AFT Pharmaceuticals | 306.21M |
| Green Cross Health | 117.75M |
| Pacific Edge | 107.17M |